Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
According to our market capitalization data, Eli Lilly (LLY) reached a market cap of $677.80 billion, securing the top spot among global Biotech companies. Novo Nordisk A/S (NOVO-B.CO) and Johnson & Johnson (JNJ) follow closely behind. The data was last updated on January 22, 2025.
| Rank | Name | Market Cap | Price | MCap(30D) | MCap(1Y) | Country |
|---|---|---|---|---|---|---|
|
201
|
 Supernus Pharmaceuticals
SUPN
|
$2.11 B | $38.17 |
6.0%
|
36.1%
|
United States
|
|
202
|
 Certara
CERT
|
$2.09 B | $12.99 |
9.0%
|
-28.9%
|
United States
|
|
203
|
 Soleno Therapeutics
SLNO
|
$2.09 B | $48.43 |
4.7%
|
-2.5%
|
United States
|
|
204
|
 GeneDx Holdings
WGS
|
$2.08 B | $75.77 |
-10.2%
|
1868.3%
|
United States
|
|
205
|
 Neuland Laboratories
NEULANDLAB.NS
|
$2.06 B | $160.24 |
-1.0%
|
137.7%
|
India
|
|
206
|
 Mesoblast
MESO
|
$2.03 B | $17.58 |
6.0%
|
902.2%
|
Australia
|
|
207
|
 IDEAYA Biosciences
IDYA
|
$2.00 B | $23.14 |
-12.3%
|
-48.0%
|
United States
|
|
208
|
 10x Genomics
TXG
|
$1.97 B | $16.31 |
2.8%
|
-64.3%
|
United States
|
|
209
|
 Agios Pharmaceuticals
AGIO
|
$1.94 B | $34.06 |
-5.2%
|
49.3%
|
United States
|
|
210
|
 Integra LifeSciences
IART
|
$1.92 B | $24.85 |
8.9%
|
-42.9%
|
United States
|
|
211
|
 Almirall
ALM.MC
|
$1.88 B | $8.81 |
4.3%
|
0.61%
|
Spain
|
|
212
|
 NeoGenomics
NEO
|
$1.86 B | $14.50 |
-17.1%
|
-11.0%
|
United States
|
|
213
|
 Tarsus Pharmaceuticals
TARS
|
$1.84 B | $48.11 |
-13.9%
|
82.1%
|
United States
|
|
214
|
 Fusion Pharmaceuticals
FUSN
|
$1.83 B | $21.55 |
0.00%
|
0.00%
|
Canada
|
|
215
|
 Iovance Biotherapeutics
IOVA
|
$1.83 B | $5.99 |
-21.1%
|
-24.0%
|
United States
|
|
216
|
 Belite Bio
BLTE
|
$1.82 B | $58.91 |
-9.3%
|
21.8%
|
United States
|
|
217
|
 Geron
GERN
|
$1.81 B | $2.99 |
-13.5%
|
35.7%
|
United States
|
|
218
|
 PeptiDream
4587.T
|
$1.78 B | $13.72 |
-16.4%
|
59.9%
|
Japan
|
|
219
|
 Wave Life Sciences
WVE
|
$1.78 B | $11.66 |
-17.2%
|
142.9%
|
Singapore
|
|
220
|
 Akero Therapeutics
AKRO
|
$1.75 B | $25.02 |
-12.0%
|
12.1%
|
United States
|
|
221
|
 Disc Medicine
IRON
|
$1.74 B | $58.50 |
-10.4%
|
-11.7%
|
United States
|
|
222
|
 Amphastar Pharmaceuticals
AMPH
|
$1.74 B | $36.14 |
-6.7%
|
-35.6%
|
United States
|
|
223
|
 Jubilant Pharmova
JUBLPHARMA.NS
|
$1.72 B | $10.85 |
-10.0%
|
70.4%
|
India
|
|
224
|
 MannKind Corp
MNKD
|
$1.70 B | $6.17 |
-10.8%
|
74.2%
|
United States
|
|
225
|
 Travere Therapeutics
TVTX
|
$1.69 B | $19.46 |
7.2%
|
97.7%
|
United States
|
|
226
|
 ProKidney
PROK
|
$1.69 B | $1.67 |
-6.7%
|
7.8%
|
United States
|
|
227
|
 Granules India
GRANULES.NS
|
$1.66 B | $6.83 |
-1.6%
|
40.4%
|
India
|
|
228
|
 Dynavax Technologies
DVAX
|
$1.63 B | $12.42 |
-3.0%
|
-12.7%
|
United States
|
|
229
|
 Nippon Shinyaku
4516.T
|
$1.63 B | $24.19 |
-4.3%
|
-25.8%
|
Japan
|
|
230
|
 Taro Pharmaceutical
TARO
|
$1.62 B | $42.97 |
0.00%
|
2.1%
|
Israel
|
|
231
|
 Celldex Therapeutics
CLDX
|
$1.61 B | $24.24 |
-5.4%
|
-38.4%
|
United States
|
|
232
|
 Arcutis Biotherapeutics
ARQT
|
$1.60 B | $13.71 |
-15.4%
|
202.6%
|
United States
|
|
233
|
 Structure Therapeutics
GPCR
|
$1.60 B | $27.94 |
-4.2%
|
-34.6%
|
United States
|
|
234
|
 BioCryst Pharmaceuticals
BCRX
|
$1.58 B | $7.62 |
-2.9%
|
35.5%
|
United States
|
|
235
|
 Galapagos NV
GLPG
|
$1.58 B | $23.93 |
-12.4%
|
-37.6%
|
Belgium
|
|
236
|
 Immunocore
IMCR
|
$1.55 B | $31.02 |
-0.35%
|
-60.4%
|
United Kingdom
|
|
237
|
 Indivior PLC
INDV
|
$1.50 B | $12.08 |
-2.8%
|
-33.1%
|
United States
|
|
238
|
 Praxis Precision Medicines
PRAX
|
$1.48 B | $79.59 |
-8.7%
|
83.6%
|
United States
|
|
239
|
 Pharma Mar
PHM.MC
|
$1.47 B | $84.93 |
2.6%
|
109.5%
|
Spain
|
|
240
|
 Evotec
EVO
|
$1.47 B | $4.13 |
-17.4%
|
-49.9%
|
Germany
|
|
241
|
 Viridian Therapeutics
VRDN
|
$1.45 B | $18.35 |
-6.1%
|
-4.3%
|
United States
|
|
242
|
 Vir Biotechnology
VIR
|
$1.45 B | $10.53 |
37.0%
|
1.4%
|
United States
|
|
243
|
 Xencor
XNCR
|
$1.45 B | $20.67 |
-20.8%
|
-2.5%
|
United States
|
|
244
|
 Sumitomo Pharma
4506.T
|
$1.44 B | $3.63 |
-3.9%
|
18.3%
|
Japan
|
|
245
|
 Dyne Therapeutics
DYN
|
$1.44 B | $14.11 |
-41.1%
|
-16.8%
|
United States
|
|
246
|
 Genus
GNS.L
|
$1.44 B | $2185.40 |
-6.6%
|
-35.5%
|
United Kingdom
|
|
247
|
 Biotest
BIO.F
|
$1.43 B | $42.73 |
0.00%
|
-1.9%
|
Germany
|
|
248
|
 Gubra A/S
GUBRA.CO
|
$1.42 B | $87.14 |
-0.95%
|
447.4%
|
Denmark
|
|
249
|
 Novavax
NVAX
|
$1.41 B | $8.83 |
-1.3%
|
97.2%
|
United States
|
|
250
|
 HBM Healthcare Investments
HBMN.SW
|
$1.41 B | $207.53 |
6.1%
|
18.7%
|
Switzerland
|
|
251
|
 Nurix Therapeutics
NRIX
|
$1.39 B | $19.68 |
-2.2%
|
139.0%
|
United States
|
|
252
|
 Molinos Agro S.A.
MOLA.BA
|
$1.39 B | $28.32 |
-12.7%
|
37.9%
|
Argentina
|
|
253
|
 Kiniksa Pharmaceuticals
KNSA
|
$1.39 B | $19.21 |
-6.2%
|
0.16%
|
|
|
254
|
 Fagron
FAGR.BR
|
$1.37 B | $18.82 |
8.4%
|
9.0%
|
Belgium
|
|
255
|
 Maravai LifeSciences
MRVI
|
$1.34 B | $5.32 |
-10.5%
|
-24.3%
|
United States
|
|
256
|
 MiMedx Group
MDXG
|
$1.32 B | $8.99 |
-0.11%
|
8.4%
|
United States
|
|
257
|
 ARS Pharmaceuticals
SPRY
|
$1.32 B | $13.55 |
10.2%
|
85.7%
|
United States
|
|
258
|
 Spyre Therapeutics
SYRE
|
$1.32 B | $21.82 |
-11.7%
|
-24.7%
|
United States
|
|
259
|
 Artivion
AORT
|
$1.29 B | $30.78 |
7.6%
|
74.5%
|
United States
|
|
260
|
 Biolife Solutions
BLFS
|
$1.27 B | $27.47 |
-1.4%
|
49.9%
|
United States
|
|
261
|
 ChemoMetec
CHEMM.CO
|
$1.27 B | $73.17 |
2.9%
|
41.7%
|
Denmark
|
|
262
|
 Ocular Therapeutix
OCUL
|
$1.26 B | $7.99 |
-3.8%
|
93.5%
|
United States
|
|
263
|
 Arvinas
ARVN
|
$1.25 B | $18.22 |
-3.6%
|
-50.4%
|
United States
|
|
264
|
 Day One Biopharmaceuticals
DAWN
|
$1.25 B | $12.38 |
-1.0%
|
-8.8%
|
United States
|
|
265
|
 Harrow Health
HROW
|
$1.23 B | $34.55 |
0.06%
|
240.9%
|
United States
|
|
266
|
 Arcus Biosciences
RCUS
|
$1.23 B | $13.40 |
-11.8%
|
-9.1%
|
United States
|
|
267
|
 Ardelyx
ARDX
|
$1.20 B | $5.05 |
8.0%
|
-42.1%
|
United States
|
|
268
|
 Syndax Pharmaceuticals
SNDX
|
$1.20 B | $14.00 |
0.08%
|
-38.4%
|
United States
|
|
269
|
 Adaptive Biotechnologies
ADPT
|
$1.18 B | $8.01 |
6.6%
|
55.8%
|
United States
|
|
270
|
 Liquidia Technologies
LQDA
|
$1.18 B | $13.95 |
11.8%
|
5.2%
|
United States
|
|
271
|
 Cosmo Pharmaceuticals
C43.F
|
$1.17 B | $71.90 |
4.5%
|
9.2%
|
Ireland
|
|
272
|
 Innoviva
INVA
|
$1.16 B | $18.53 |
4.5%
|
11.5%
|
United States
|
|
273
|
 Intellia Therapeutics
NTLA
|
$1.12 B | $11.01 |
-21.2%
|
-63.2%
|
United States
|
|
274
|
 Myriad Genetics
MYGN
|
$1.12 B | $12.28 |
-9.8%
|
-42.2%
|
United States
|
|
275
|
 Rocket Pharmaceuticals
RCKT
|
$1.11 B | $10.48 |
-11.7%
|
-63.5%
|
United States
|
|
276
|
 Faes Farma
FAE.MC
|
$1.11 B | $3.57 |
0.89%
|
15.9%
|
Spain
|
|
277
|
 Aurinia Pharmaceuticals
AUPH
|
$1.11 B | $7.73 |
-13.9%
|
-4.0%
|
Canada
|
|
278
|
 SPIMACO (Saudi Pharmaceutical Industries and Medical Appliances Corporation)
2070.SR
|
$1.10 B | $9.22 |
8.1%
|
-9.1%
|
Saudi Arabia
|
|
279
|
 Calliditas Therapeutics
CALT
|
$1.10 B | $40.00 |
0.00%
|
71.5%
|
Sweden
|
|
280
|
 Enliven Therapeutics
ELVN
|
$1.08 B | $22.05 |
-7.3%
|
42.1%
|
United States
|
|
281
|
 Pharvaris
PHVS
|
$1.06 B | $19.54 |
1.5%
|
-35.3%
|
Netherlands
|
|
282
|
 Tilray
TLRY
|
$1.06 B | $1.13 |
-17.0%
|
-42.4%
|
Canada
|
|
283
|
 Collegium Pharmaceutical
COLL
|
$1.05 B | $32.55 |
14.8%
|
1.2%
|
United States
|
|
284
|
 AbCellera
ABCL
|
$1.04 B | $3.53 |
3.7%
|
-42.4%
|
Canada
|
|
285
|
 Pacira Biosciences
PCRX
|
$1.04 B | $22.45 |
14.8%
|
-31.0%
|
United States
|
|
286
|
 Zymeworks
ZYME
|
$1.01 B | $14.67 |
1.1%
|
39.0%
|
Canada
|
|
287
|
 Replimune
REPL
|
$1.00 B | $13.02 |
-18.9%
|
29.0%
|
United States
|
|
288
|
 PolyPeptide Group
PPGN.SW
|
$0.99 B | $30.14 |
-8.3%
|
71.9%
|
Switzerland
|
|
289
|
 PolyNovo
PNV.AX
|
$0.99 B | $1.44 |
6.5%
|
23.8%
|
Australia
|
|
290
|
 SD BioSensor
137310.KS
|
$0.97 B | $7.89 |
9.8%
|
4.8%
|
South Korea
|
|
291
|
 Oculis Holding AG
OCS
|
$0.95 B | $22.69 |
33.3%
|
104.9%
|
Switzerland
|
|
292
|
 Poseida Therapeutics
PSTX
|
$0.93 B | $9.50 |
0.11%
|
197.8%
|
United States
|
|
293
|
 Gyre Therapeutics
GYRE
|
$0.92 B | $10.70 |
-8.0%
|
-32.2%
|
United States
|
|
294
|
 Bicycle Therapeutics
BCYC
|
$0.91 B | $13.20 |
0.82%
|
-16.4%
|
United Kingdom
|
|
295
|
 Cogent Biosciences
COGT
|
$0.91 B | $8.20 |
2.2%
|
73.4%
|
United States
|
|
296
|
 ArriVent BioPharma
AVBP
|
$0.90 B | $26.63 |
-8.3%
|
22.0%
|
United States
|
|
297
|
 Evolus
EOLS
|
$0.89 B | $14.13 |
-3.1%
|
-10.6%
|
United States
|
|
298
|
 Nuvation Bio
NUVB
|
$0.89 B | $2.65 |
-11.0%
|
51.2%
|
United States
|
|
299
|
 Curevac
CVAC
|
$0.89 B | $3.96 |
38.5%
|
12.2%
|
Germany
|
|
300
|
 FDC India
FDC.NS
|
$0.88 B | $5.39 |
-4.6%
|
14.6%
|
India
|
|
301
|
 Anavex Life Sciences
AVXL
|
$0.85 B | $9.99 |
-15.3%
|
39.5%
|
United States
|
|
302
|
 Axogen
AXGN
|
$0.83 B | $18.89 |
11.3%
|
104.2%
|
United States
|
|
303
|
 Vetoquinol
VETO.PA
|
$0.83 B | $69.40 |
-2.3%
|
-30.8%
|
France
|
|
304
|
 Relay Therapeutics
RLAY
|
$0.82 B | $4.92 |
5.4%
|
-55.4%
|
United States
|
|
305
|
 uniQure
QURE
|
$0.82 B | $15.29 |
-14.1%
|
154.7%
|
Netherlands
|
|
306
|
 Tyra Biosciences
TYRA
|
$0.80 B | $15.80 |
14.9%
|
21.1%
|
United States
|
|
307
|
 Avid Bioservices
CDMO
|
$0.80 B | $12.45 |
1.1%
|
84.4%
|
United States
|
|
308
|
 89bio
ETNB
|
$0.79 B | $6.75 |
-20.5%
|
-42.5%
|
United States
|
|
309
|
 Sana Biotechnology
SANA
|
$0.78 B | $3.50 |
80.6%
|
-40.9%
|
United States
|
|
310
|
 Prothena
PRTA
|
$0.78 B | $14.43 |
-8.4%
|
-58.1%
|
Ireland
|
|
311
|
 Avadel Pharmaceuticals
AVDL
|
$0.77 B | $8.00 |
-22.8%
|
-44.2%
|
Ireland
|
|
312
|
 Ginkgo Bioworks
DNA
|
$0.74 B | $12.90 |
15.6%
|
-78.7%
|
United States
|
|
313
|
 SI-BONE
SIBN
|
$0.71 B | $16.88 |
25.8%
|
-12.3%
|
United States
|
|
314
|
 BML, Inc.
4694.T
|
$0.70 B | $17.96 |
-5.6%
|
-2.1%
|
Japan
|
|
315
|
 Opthea
OPT
|
$0.68 B | $4.40 |
21.5%
|
63.9%
|
Australia
|
|
316
|
 LENZ Therapeutics
LENZ
|
$0.68 B | $24.80 |
-28.6%
|
439.6%
|
United States
|
|
317
|
 Capricor Therapeutics
CAPR
|
$0.68 B | $14.98 |
-2.2%
|
231.7%
|
United States
|
|
318
|
 Pliant Therapeutics
PLRX
|
$0.68 B | $11.10 |
-16.9%
|
-35.7%
|
United States
|
|
319
|
 Verve Therapeutics
VERV
|
$0.67 B | $7.90 |
6.4%
|
-49.5%
|
United States
|
|
320
|
 Immatics
IMTX
|
$0.66 B | $5.44 |
-23.9%
|
-53.4%
|
Germany
|
|
321
|
 SPARC
SPARC.NS
|
$0.66 B | $2.03 |
-9.9%
|
-52.3%
|
India
|
|
322
|
 Exscientia
EXAI
|
$0.63 B | $4.84 |
0.00%
|
-20.8%
|
United Kingdom
|
|
323
|
 Immunome
IMNM
|
$0.63 B | $10.12 |
-9.3%
|
-33.4%
|
United States
|
|
324
|
 Strides Pharma
STAR.NS
|
$0.62 B | $6.73 |
-7.9%
|
-6.9%
|
India
|
|
325
|
 Pharming Group
PHAR
|
$0.62 B | $9.13 |
-9.5%
|
-20.4%
|
Netherlands
|
|
326
|
 Tectonic Therapeutic
TECX
|
$0.61 B | $41.61 |
-19.1%
|
156.3%
|
United States
|
|
327
|
 Cullinan Therapeutics
CGEM
|
$0.61 B | $10.50 |
-16.4%
|
-17.9%
|
United States
|
|
328
|
 Arbutus Biopharma
ABUS
|
$0.61 B | $3.22 |
0.63%
|
33.3%
|
United States
|
|
329
|
 Kura Oncology
KURA
|
$0.60 B | $7.76 |
-18.1%
|
-45.9%
|
United States
|
|
330
|
 Ironwood Pharmaceuticals
IRWD
|
$0.60 B | $3.72 |
-20.6%
|
-72.8%
|
United States
|
|
331
|
 CARGO Therapeutics
CRGX
|
$0.59 B | $12.86 |
-15.5%
|
-47.1%
|
United States
|
|
332
|
 Emergent BioSolutions
EBS
|
$0.59 B | $10.82 |
19.0%
|
401.5%
|
United States
|
|
333
|
 Humacyte
HUMA
|
$0.59 B | $4.55 |
-2.2%
|
51.5%
|
United States
|
|
334
|
 EyePoint Pharmaceuticals
EYPT
|
$0.58 B | $8.49 |
2.0%
|
-70.0%
|
United States
|
|
335
|
 Autolus Therapeutics
AUTL
|
$0.58 B | $2.17 |
7.1%
|
-56.3%
|
United Kingdom
|
|
336
|
 Erasca
ERAS
|
$0.55 B | $1.93 |
-28.0%
|
7.6%
|
United States
|
|
337
|
 Omeros Corporation
OMER
|
$0.54 B | $9.32 |
-6.7%
|
173.6%
|
United States
|
|
338
|
 Stoke Therapeutics
STOK
|
$0.53 B | $10.07 |
-17.3%
|
89.9%
|
United States
|
|
339
|
 KYORIN Pharmaceutical
4569.T
|
$0.53 B | $9.26 |
-0.62%
|
-16.7%
|
Japan
|
|
340
|
 MaxCyte
MXCT
|
$0.53 B | $5.01 |
20.2%
|
-3.3%
|
United States
|
|
341
|
 Fulgent Genetics
FLGT
|
$0.52 B | $17.00 |
-7.6%
|
-34.9%
|
United States
|
|
342
|
 Akebia Therapeutics
AKBA
|
$0.52 B | $2.38 |
11.3%
|
47.9%
|
United States
|
|
343
|
 Mind Medicine
MNMD
|
$0.52 B | $7.08 |
-2.3%
|
90.3%
|
United States
|
|
344
|
 Pacific Biosciences
PACB
|
$0.52 B | $1.76 |
-15.9%
|
-76.7%
|
United States
|
|
345
|
 Hikal
HIKAL.NS
|
$0.52 B | $4.19 |
-1.0%
|
29.1%
|
India
|
|
346
|
 Mineralys Therapeutics
MLYS
|
$0.51 B | $10.19 |
-27.8%
|
-2.2%
|
United States
|
|
347
|
 Rapport Therapeutics
RAPP
|
$0.51 B | $13.86 |
-31.3%
|
-39.0%
|
United States
|
|
348
|
 AnaptysBio
ANAB
|
$0.50 B | $16.32 |
14.1%
|
-34.0%
|
United States
|
|
349
|
 Quanterix
QTRX
|
$0.50 B | $10.01 |
-15.7%
|
-62.4%
|
United States
|
|
350
|
 Altimmune
ALT
|
$0.49 B | $6.95 |
-9.1%
|
-31.5%
|
United States
|
|
351
|
 Xeris Pharmaceuticals
XERS
|
$0.49 B | $3.31 |
-7.8%
|
31.7%
|
United States
|
|
352
|
 Savara Pharmaceuticals
SVRA
|
$0.48 B | $2.83 |
-8.4%
|
-42.0%
|
United States
|
|
353
|
 Cartesian Therapeutics
RNAC
|
$0.48 B | $18.83 |
4.4%
|
-17.4%
|
United States
|
|
354
|
 Entrada Therapeutics
TRDA
|
$0.48 B | $12.83 |
-27.7%
|
-20.9%
|
United States
|
|
355
|
 Personalis
PSNL
|
$0.48 B | $5.64 |
-19.7%
|
200.0%
|
United States
|
|
356
|
 Boiron
BOI.PA
|
$0.48 B | $27.41 |
0.00%
|
-33.7%
|
France
|
|
357
|
 Phathom Pharmaceuticals
PHAT
|
$0.47 B | $6.93 |
-7.2%
|
-1.7%
|
United States
|
|
358
|
 MeiraGTx
MGTX
|
$0.47 B | $6.05 |
1.5%
|
-5.3%
|
United States
|
|
359
|
 Mereo BioPharma Group
MREO
|
$0.46 B | $2.98 |
-1.3%
|
25.8%
|
United Kingdom
|
|
360
|
 Theravance Biopharma
TBPH
|
$0.46 B | $9.41 |
-7.1%
|
-7.9%
|
|
|
361
|
 Arcturus Therapeutics
ARCT
|
$0.46 B | $17.04 |
1.6%
|
-51.5%
|
United States
|
|
362
|
 GH Research
GHRS
|
$0.46 B | $8.80 |
26.8%
|
47.1%
|
Ireland
|
|
363
|
 Keros Therapeutics
KROS
|
$0.46 B | $11.30 |
-35.0%
|
-80.5%
|
United States
|
|
364
|
 SIGA Technologies
SIGA
|
$0.46 B | $6.39 |
3.8%
|
32.7%
|
United States
|
|
365
|
 Tourmaline Bio
TRML
|
$0.46 B | $17.75 |
-15.9%
|
-53.2%
|
United States
|
|
366
|
 Absci
ABSI
|
$0.45 B | $3.89 |
-3.7%
|
-20.5%
|
United States
|
|
367
|
 Annexon
ANNX
|
$0.45 B | $4.18 |
-19.7%
|
-10.4%
|
United States
|
|
368
|
 ChromaDex
CDXC
|
$0.44 B | $5.80 |
9.2%
|
336.8%
|
United States
|
|
369
|
 Aarti Drugs
AARTIDRUGS.NS
|
$0.44 B | $4.82 |
-7.2%
|
-21.4%
|
India
|
|
370
|
 Organogenesis
ORGO
|
$0.44 B | $3.48 |
5.0%
|
-8.9%
|
United States
|
|
371
|
 Zevra Therapeutics
ZVRA
|
$0.43 B | $8.09 |
-6.3%
|
35.5%
|
United States
|
|
372
|
 Kamada
KMDA
|
$0.43 B | $7.44 |
17.0%
|
25.8%
|
Israel
|
|
373
|
 Sage Therapeutics
SAGE
|
$0.43 B | $6.97 |
29.2%
|
-73.5%
|
United States
|
|
374
|
 Esperion Therapeutics
ESPR
|
$0.43 B | $2.16 |
-3.9%
|
3.8%
|
United States
|
|
375
|
 Kodiak Sciences
KOD
|
$0.42 B | $8.05 |
-27.4%
|
98.6%
|
United States
|
|
376
|
 UroGen Pharma
URGN
|
$0.42 B | $10.02 |
-5.1%
|
-32.0%
|
United States
|
|
377
|
 KalVista Pharmaceuticals
KALV
|
$0.42 B | $8.53 |
-5.3%
|
-33.7%
|
United States
|
|
378
|
 PureTech Health
PRTC
|
$0.42 B | $17.54 |
-12.1%
|
-28.6%
|
United States
|
|
379
|
 Olema Pharmaceuticals
OLMA
|
$0.42 B | $5.63 |
-10.4%
|
-49.4%
|
United States
|
|
380
|
 Prime Medicine
PRME
|
$0.41 B | $3.12 |
4.7%
|
-56.3%
|
United States
|
|
381
|
 Codexis
CDXS
|
$0.40 B | $4.95 |
0.00%
|
67.2%
|
United States
|
|
382
|
 Allogene Therapeutics
ALLO
|
$0.40 B | $1.92 |
-12.9%
|
-43.3%
|
United States
|
|
383
|
 Abivax
ABVX
|
$0.40 B | $6.28 |
-16.1%
|
-46.6%
|
France
|
|
384
|
 Terns Pharmaceuticals
TERN
|
$0.40 B | $4.70 |
-23.6%
|
-18.9%
|
United States
|
|
385
|
 RPG Life Sciences
RPGLIFE.NS
|
$0.40 B | $24.03 |
-3.9%
|
32.7%
|
India
|
|
386
|
 Aura Biosciences
AURA
|
$0.40 B | $7.91 |
-5.6%
|
1.7%
|
United States
|
|
387
|
 OmniAb
OABI
|
$0.39 B | $3.20 |
-9.1%
|
-47.6%
|
United States
|
|
388
|
 Alumis
ALMS
|
$0.38 B | $7.01 |
-4.7%
|
-42.4%
|
United States
|
|
389
|
 REGENXBIO
RGNX
|
$0.38 B | $7.68 |
-0.41%
|
-48.1%
|
United States
|
|
390
|
 Revance Therapeutics
RVNC
|
$0.38 B | $3.64 |
19.5%
|
-39.0%
|
United States
|
|
391
|
 Rigel Pharmaceuticals
RIGL
|
$0.38 B | $21.58 |
22.4%
|
58.5%
|
United States
|
|
392
|
 Valneva SE
VALN
|
$0.38 B | $4.66 |
8.4%
|
-47.2%
|
France
|
|
393
|
 G1 Therapeutics
GTHX
|
$0.38 B | $7.15 |
0.00%
|
89.2%
|
United States
|
|
394
|
 Quantum-Si
QSI
|
$0.37 B | $2.36 |
72.3%
|
23.1%
|
United States
|
|
395
|
 enGene
ENGN
|
$0.37 B | $7.27 |
10.3%
|
-3.5%
|
Canada
|
|
396
|
 Shinpoong Pharm
019170.KS
|
$0.36 B | $7.40 |
5.3%
|
-11.6%
|
South Korea
|
|
397
|
 Korro Bio
KRRO
|
$0.36 B | $38.56 |
-14.5%
|
-13.9%
|
United States
|
|
398
|
 Compass Therapeutics
CMPX
|
$0.36 B | $2.59 |
73.3%
|
80.6%
|
United States
|
|
399
|
 Trevi Therapeutics
TRVI
|
$0.35 B | $3.94 |
-6.0%
|
178.5%
|
United States
|
|
400
|
 Corvus Pharmaceuticals
CRVS
|
$0.34 B | $5.36 |
2.2%
|
145.6%
|
United States
|